-+ 0.00%
-+ 0.00%
-+ 0.00%

ZANVASTRO™ (ZILGANERSEN) APPROVED BY THE FDA AS THE FIRST AND ONLY DISEASE MODIFYING TREATMENT FOR ALEXANDER DISEASE (AXD) IN PEDIATRIC AND ADULT PATIENTS

Reuters·09/03/2026 23:47:02

Please log in to view news